Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Absolute Bioavailability Study of LY2835219 in Healthy Subjects Using the Intravenous Tracer Method

NCT02327143 is registered in ClinicalTrials.gov with Eli Lilly and Company as lead sponsor.

NCT NCT02327143
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02327143 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Absolute Bioavailability Study of LY2835219 in Healthy Subjects Using the Intravenous Tracer Method
Lead sponsor
Eli Lilly and Company
Phase
Phase 1
Overall status
Completed
Start date
January 31, 2015
Completion date
February 28, 2015
Enrollment
11 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

healthy volunteers